ACMJ
Anatolian Current Medical Journal

Anatolian Current Medical Journal (ACMJ) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

eISSN: 2718-0115
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study
Abstract
Aims: Tumor necrosis factor (TNF) inhibitors are widely used in the treatment of inflammatory and autoimmune diseases; however, they increase the risk of latent tuberculosis (TB) infection reactivation and active tuberculosis. This study aimed to evaluate tuberculosis-related knowledge and awareness among patients receiving anti-TNF therapy.
Methods: This single-center, cross-sectional survey study included adult patients receiving anti-TNF therapy who attended a pulmonology clinic between May and November 2023. An 18-item questionnaire was administered through face-to-face interviews. A composite TB awareness score (range: 0-6) was calculated based on six items, and participants were categorized as having low (0-2), moderate (3-4), or high (5-6) awareness. Associations between awareness levels and clinical characteristics were analyzed, and ordinal logistic regression was performed to identify independent predictors.
Results: A total of 145 patients were included. The patients’ mean age was 45.29±12.89 years, and 59.3% were female. Although 87.6% of participants believed that pulmonology consultation was necessary for anti-TNF approval, only 40.7% correctly identified TB screening as the primary purpose of this evaluation, while 46.9% perceived it as only a required signature. Nearly half of the participants (45.5%) reported no knowledge of TB symptoms. Overall, 32.4% of patients had low awareness, 55.2% moderate awareness, and 12.4% high awareness. In univariate ordinal logistic regression analyses, high school education was associated with lower awareness compared to university education, while TB prophylaxis was associated with higher awareness. In multivariate ordinal logistic regression analyses, primary school education was associated with lower awareness compared to university education.
Conclusion: TB awareness among patients receiving anti-TNF therapy remained limited, even with regular clinical follow-up. Many patients perceived pulmonology consultations as administrative procedures rather than infection surveillance measures. These findings suggest that structured and repeated patient-centered educational interventions may be necessary to enhance TB awareness and promote appropriate preventive behaviors in this high-risk population.

Keywords : Tumor necrosis factor inhibitors, tuberculosis, latent tuberculosis, health knowledge, survey

Download Article


1. World Health Organization. Global tuberculosis report 2023. Geneva, Switzerland: World Health Organization; 2023.
2. Thavarajah K, Wu P, Rhew EJ, Yeldandi AK, Kamp DW. Pulmonary complications of tumor necrosis factor-targeted therapy. Respir Med. 2009;103(5):661-669. doi:10.1016/j.rmed.2009.01.002
3. Republic of Turkey Ministry of Health. Tüberküloz tanı ve tedavi rehberi [Tuberculosis diagnosis and treatment guideline]. Republic of Turkey Ministry of Health; 2019.
4. Algood HM, Lin PL, Flynn JL. Tumor necrosis factor and chemokine interactions in the formation and maintenance of granulomas in tuberculosis. Clin Infect Dis. 2005;41 Suppl 3:S189-S193. doi:10.1086/ 429994
5. British Thoracic Society Standards of Care Committee. BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment. Thorax. 2005;60(10):800-805. doi:10.1136/thx.2005.046797
6. Baddley JW, Cantini F, Goletti D, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) consensus document on the safety of targeted and biological therapies: an infectious diseases perspective (soluble immune effector molecules [i]: anti-tumor necrosis factor-? agents). Clin Microbiol Infect. 2018;24 Suppl 2:S10-S20. doi:10. 1016/j.cmi.2017.12.025
7. Kanbay, A., & Yakar, H. İ. Biyolojik tedaviler ve tüberküloza yaklaşım. Karadağ AS, editör. Türkiye Klinikleri, Dermatolojide Biyolojik Tedaviler. 2021:12-16.
8. Republic of Turkey Ministry of Health, Public Health Institution of Turkey. Anti-TNF kullanan hastalarda tüberküloz rehberi. Published online 2014. Accessed March 23, 2022.
9. Godfrey MS, Friedman LN. Tuberculosis and biologic therapies: anti-tumor necrosis factor-? and beyond. Clin Chest Med. 2019;40(4):721-739. doi:10.1016/j.ccm.2019.07.003
10. Cagatay T, Aydin M, Sunmez S, et al. Follow-up results of 702 patients receiving tumor necrosis factor-? antagonists and evaluation of risk of tuberculosis. Rheumatol Int. 2010;30(11):1459-1463. doi:10.1007/s00296- 009-1170-6
11. Elbek O, Uyar M, Aydin N, et al. Increased risk of tuberculosis in patients treated with antitumor necrosis factor alpha. Clin Rheumatol. 2009;28(4):421-426. doi:10.1007/s10067-008-1067-x
12. Kigozi NG, Heunis JC, Engelbrecht MC, Janse van Rensburg AP, van Rensburg HCJD. Tuberculosis knowledge, attitudes and practices of patients at primary health care facilities in a South African metropolitan: research towards improved health education. BMC Public Health. 2017;17(1):795. doi:10.1186/s12889-017-4825-3
13. Bisallah CI, Rampal L, Lye MS, et al. Effectiveness of health education intervention in improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria-a randomized control trial. PLoS One. 2018;13(2):e0192276. doi:10.1371/journal.pone.0192276
14. Chauhan A, Parmar M, Dash GC, et al. Health literacy and tuberculosis control: systematic review and meta-analysis. Bull World Health Organ. 2024;102(6):421-431. doi:10.2471/BLT.23.290396
15. Nisar MK, Rafiq A, Östör AJ. Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom. Clin Rheumatol. 2015;34(12):2141-2145. doi:10.1007/s10067-015-3099-3
Article available in :
Volume 8, Issue 3, 2026
Page : 435-441
https://doi.org/10.38053/acmj.1893502
Article Information
Received : 21 Şub 2026
Accepted : 08 Nis 2026
Published : 22 May 2026
Corresponding Author :

Ezgi Erdem Türe: Department of Chest Diseases, Ankara Etlik City Hospital, Ankara, Turkiye

[email protected]
Citation : Erdem Türe E, Doğan D, Timurhan YG, Özdoğan Algın M, Duru S. Tuberculosis awareness in patients receiving anti-TNF therapy: a survey study. Anatolian Curr Med J. 2026;8(3):435-441. doi:10.38053/acmj.1893502

Read: 201
Download : 81
Cited: 0
_Footer